Dan McGarvey

Integrum is an investment firm focused on partnering with technology-enabled services companies. Integrum was founded by a team of proven leaders with a vision to build a different type of investing platform benefiting from their diverse and complementary backgrounds and vast relationship network.

From the first guidewire to the first drug eluting stent, for over 60 years Cordis has remained at the heart of cardiovascular innovation. Cordis is again at the forefront of transformation in the cardiovascular space, leveraging internal development, partnership with the CordisX innovation incubator and targeted acquisitions of industry-disrupting technology. These innovations, brought to market with the strength of Cordis’ global footprint and operations, seek to transform the interventional space through enhanced clinical outcomes, customer-centric services, and impactful educational platforms – doubling-down on our commitment to the interventional community. Cordis will Go Beyond, to relentlessly pursue our dedication to transform cardiovascular care.

Integrum is an investment firm focused on partnering with technology-enabled services companies. Integrum was founded by a team of proven leaders with a vision to build a different type of investing platform benefiting from their diverse and complementary backgrounds and vast relationship network.

From the first guidewire to the first drug eluting stent, for over 60 years Cordis has remained at the heart of cardiovascular innovation. Cordis is again at the forefront of transformation in the cardiovascular space, leveraging internal development, partnership with the CordisX innovation incubator and targeted acquisitions of industry-disrupting technology. These innovations, brought to market with the strength of Cordis’ global footprint and operations, seek to transform the interventional space through enhanced clinical outcomes, customer-centric services, and impactful educational platforms – doubling-down on our commitment to the interventional community. Cordis will Go Beyond, to relentlessly pursue our dedication to transform cardiovascular care.

Founded in 1984, Hellman & Friedman (H&F) is one of the oldest and most experienced private equity investment firms operating today. We are well respected for our distinctive investment philosophy and focused approach targeting large-scale equity investments in companies in select sectors. H&F has offices in San Francisco, New York and London. For more information, visit www.hf.com.

The Tourette Association of America is the premier nationwide organization dedicated to improving the quality of life for those affected by Tourette Syndrome (TS) and related Tic Disorders, who are frequently misunderstood by the general public and the medical community. Our efforts are focused on “awareness, research and support.” The TAA is the largest and most active national network working to educate the general public and the medical community about TS to: • Raise public awareness and foster social acceptance • Advance scientific understanding, treatment options and care • Educate professionals to better serve the needs of children, adults and families challenged by Tourette and Tic Disorders • Advocate for public policies and services that promote positive school, work and social environments • Provide help, hope and a supportive community across the nation • Empower our community to deal with the complexities of this spectrum of disorders Today it is estimated that 1 in 160 (0.6%) school-aged children in the United States has Tourette and that 1 in 100 school-aged children in the United States has TS or another Tic Disorder. Thousands of children and adults may be experiencing the wide range of often misinterpreted behaviors associated with TS and Tic Disorders without understanding the cause—or realizing that help is available. This can result in life-long learning or emotional issues, which could be prevented. Visit Tourette.org to learn more!